NEW YORK, NY / ACCESSWIRE / February 4, 2020 / The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. There is no cost to participate in the suit. If you suffered a loss, you have until the lead plaintiff deadline to request that the court appoint you as lead plaintiff.
Adamas Pharmaceuticals, Inc. (ADMS)
Class Period: August 8, 2017 to September 30, 2019
Lead Plaintiff Deadline: February 10, 2020
According to the complaint, Adamas Pharmaceuticals, Inc. allegedly made materially false and/or misleading statements and/or failed to disclose that: (1) health insurers were excluding Adamas's primary product, GOCOVRI, from their prescription formularies or requiring patients to use "step therapy" - i.e., making patients try immediate-release amantadine prior to covering GOCOVRI; (2) the rapid increase in physicians prescribing GOCOVRI during the Class Period was not due to its efficacy; and (3) as a result of the foregoing, the Company's financial statements about Adamas's business, operations, and prospects were materially false and misleading at all relevant times.
Learn about your recoverable losses in ADMS: http://www.kleinstocklaw.com/pslra-1/adamas-pharmaceuticals-inc-loss-submission-form?id=5411&from=1
Forescout Technologies, Inc. (FSCT)
Class Period: February 7, 2019 to October 9, 2019
Lead Plaintiff Deadline: March 2, 2020
The complaint alleges Forescout Technologies, Inc. made materially false and/or misleading statements and/or failed to disclose that: (i) Forescout was experiencing significant volatility with respect to large deals and issues related to the timing and execution of deals in the Company's pipeline, especially in Europe, the Middle East, and Africa; (ii) the foregoing was reasonably likely to have a material negative impact on the Company's financial results; and (iii) as a result, the Company's public statements were materially false and misleading at all relevant times.
Learn about your recoverable losses in FSCT: http://www.kleinstocklaw.com/pslra-1/forescout-technologies-inc-loss-submission-form?id=5411&from=1
Portola Pharmaceuticals, Inc. (PTLA)
Class Period: November 5, 2019 to January 9, 2020
Lead Plaintiff Deadline: March 16, 2020
The PTLA lawsuit alleges Portola Pharmaceuticals, Inc. made materially false and/or misleading statements and/or failed to disclose during the class period that: (1) Portola's internal control over financial reporting regarding reserve for product returns was not effective; (2) Portola was shipping longer-dated product with 36-month shelf life; (3) Portola had not established adequate reserve for returns of prior shipments of short-dated product; (4) as a result, Portola was reasonably likely to need to "catch up" on accounting for return reserves; and (5) as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.